Implications of the first FDA-approved anticoagulant in pediatrics: One
ship has sailed but the next ones are at the dock – Highlight On
[PBC-19-1346.R2]
Guy Young
Children's Hospital of Los Angeles
Corresponding Author:gyoung@chla.usc.edu
Author Profile10 Sep 2020Submission Checks Completed 10 Sep 2020Assigned to Editor
10 Sep 2020Submitted to Pediatric Blood & Cancer 11 Sep 2020Editorial Decision: Accept
